|
Delayed
Nasdaq Stockholm
08:25:26 2026-10-08 EDT
|
5-day change | 1st Jan Change | ||
| 6.880 SEK | -3.23% |
|
-50.00% | -77.14% |
| 10-06 | CEO interview with Nikolaj Sørensen at Orexo ahead of the upcoming offering | FW |
| 10-06 | Orexo Plans SEK250 Million Rights Issue to Fund Drug Development | MT |
MarketScreener Strategies
Search
No results match your criteria
- Stock Market
- Stocks
- ORX Stock
- News Orexo AB
- MarketScreener Strategies
Select your edition
All financial news and data tailored to specific country editions
